A new study identifies the FXR bile receptor as a key therapeutic target to prevent sleep apnea cardiovascular complications.

Apple, Samsung, Garmin, and Oura are racing toward smartwatch blood sugar tracking, but today’s wearables still depend on ...

Computational point-of-care sensors can significantly improve access to diagnostics by enabling rapid patient testing outside ...